Mechanisms of constitutive NF-κB activation in human prostate cancer cells

Authors

  • Junghan Suh,

    1. Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey
    2. Department of Molecular Genetics and Microbiology, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey
    Search for more papers by this author
  • Faribourz Payvandi,

    1. Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey
    Current affiliation:
    1. Celgene Corporation, Warren, New Jersey
    Search for more papers by this author
  • Leonard C. Edelstein,

    1. Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey
    2. Department of Biochemistry, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey
    Search for more papers by this author
  • Peter S. Amenta,

    1. Department of Pathology, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey
    2. Cancer Institute of New Jersey, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey
    Search for more papers by this author
  • Wei-Xing Zong,

    1. Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey
    2. Department of Biochemistry, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey
    Current affiliation:
    1. Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania
    Search for more papers by this author
  • Céline Gélinas,

    1. Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey
    2. Department of Biochemistry, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey
    3. Cancer Institute of New Jersey, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey
    Search for more papers by this author
  • Arnold B. Rabson

    Corresponding author
    1. Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey
    2. Department of Molecular Genetics and Microbiology, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey
    3. Department of Pathology, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey
    4. Cancer Institute of New Jersey, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey
    • CABM, 679 Hoes Lane, Piscataway, NJ 08854.
    Search for more papers by this author

Abstract

BACKGROUND

Activation of the NF-κB transcription factor has been previously demonstrated in two androgen receptor negative prostate cancer cell lines. We wished to extend this work to additional prostate cancer cells and to characterize the mechanisms responsible for constitutive NF-κB activation.

METHODS

Electrophoretic mobility shift assays were performed to measure NF-κB DNA-binding activity in prostate cancer cell lines, and immunohistochemistry was performed to detect nuclear localization of NF-κB in prostate cancer tissues. Western blot analysis was used to study the status of IκBα. Transient transfection assays were employed to characterize the contributions of IκB kinase (IKK), MAPK kinase kinases (MAPKKKs), androgen receptor (AR), and tyrosine phosphorylation to the constitutive activation of NF-κB in the prostate cancer cell lines.

RESULTS

Constitutive NF-κB activity was observed in AR-negative cell lines as well as in the prostate cancer patient samples, but was not present in AR positive cells. A “super-repressor” IκBα, as well as dominant negative forms of IKKβ and NF-κB-inducing kinase (NIK), and tyrosine kinase inhibition were able to suppress NF-κB activity in the cells with constitutive activation.

CONCLUSIONS

The constitutive activation of NF-κB observed in prostate cancer cells is likely due to a signal transduction pathway involving tyrosine kinases, NIK, and IKK activation. Prostate 52:183–200, 2002. © 2002 Wiley-Liss, Inc.

Ancillary